Related Experiment Video
Updated: May 15, 2026

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Positive correlation between the dysregulation of transforming growth factor-β1 and aneurysmal pathological changes
Koung Li Kim1, Jeong Hoon Yang, Sun-Hwa Song
1Department of Medicine, Samsung Medical Center, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Seoul, Korea.
Background:
Our goal was to investigate the correlation between the dysregulation of transforming growth factor-β1 (TGF-β1) and cystic medial degeneration in the aortic aneurysmal tissues of in Marfan syndrome (MFS) patients. Although aortic aneurysm in animal models of MFS is related to the dysregulation of TGF-β, it has yet to be determined whether TGF-β dysregulation correlates with pathogenic aneurysmal characteristics in MFS patients.
Methods And Results:
Compared with aortic tissue from normal individuals, the medial layers of aortic tissue from MFS patients exhibited profound cystic medial degeneration and cellular apoptosis. These histopathologic changes positively correlated with the extent of TGF-β1 signaling activation (Smad2 phosphorylation) in aneurysmal aortic tissue. In addition, the level of TGF-β1 expression in peripheral blood and aneurysmal aortic tissues was significantly elevated in MFS patients. A significant positive correlation was observed between the plasma level of active TGF-β1 in MFS patients and the severity of cystic medial degeneration and Smad2 phosphorylation in aneurysmal aortic medial layers.
Conclusions:
We found a strong association between the dysregulation of TGF-β1 and aortic pathogenesis in human MFS patients. This suggests that the plasma concentration of TGF-β1 in MFS patients might be a useful biomarker of the progression of aortic aneurysms.
Insights
Transforming growth factor-β1 (TGF-β1) dysregulation is strongly linked to aortic disease in Marfan syndrome (MFS) patients. Elevated TGF-β1 levels may serve as a biomarker for MFS aortic aneurysm progression.
Area of Science:
- Cardiovascular Biology
- Genetics
- Pathology
Background:
- Marfan syndrome (MFS) is a genetic disorder affecting connective tissue, often leading to aortic aneurysms.
- While TGF-β signaling is implicated in MFS animal models, its role in human MFS aortic pathogenesis remains unclear.
Purpose of the Study:
- To investigate the correlation between transforming growth factor-β1 (TGF-β1) dysregulation and cystic medial degeneration in MFS patients' aortic tissues.
- To determine if TGF-β1 dysregulation is associated with pathogenic features of aortic aneurysms in humans with MFS.
Main Methods:
- Histopathological analysis of aortic tissues from MFS patients and normal individuals.
- Assessment of TGF-β1 expression and signaling activation (Smad2 phosphorylation) in aortic tissues and plasma.
- Correlation analysis between TGF-β1 levels, signaling, and histopathological findings.
Main Results:
- MFS aortic tissues showed significant cystic medial degeneration and apoptosis compared to controls.
- Increased TGF-β1 expression and Smad2 phosphorylation were observed in MFS aortic tissues and plasma.
- A positive correlation existed between TGF-β1 levels, signaling activation, and the severity of aortic degeneration in MFS patients.
Conclusions:
- A strong association between TGF-β1 dysregulation and aortic pathogenesis in human MFS patients was identified.
- Plasma TGF-β1 concentration may serve as a potential biomarker for monitoring aortic aneurysm progression in MFS.
Related Concept Videos
TGF - β Signaling Pathway
Aneurysm I: Introduction
Intracellular Signaling Affects Focal Adhesions
Some...
Regulation of Angiogenesis and Blood Supply

